Effectiveness of Risk Minimisation Interventions for Vandetanib in Canada
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Vandetanib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 12 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jan 2013 New trial record